Johnson & Johnson announced positive topline results from its Phase 2 randomized placebo-controlled JASMINE study. The drug ...
GlobalData on MSN
HUTCHMED begins Phase III segment of metastatic PDAC treatment trial
HUTCHMED has commenced the Phase III stage of its ongoing Phase II/III clinical trial assessing the combination of ...
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, confirms the planned announcement of the results from cohort 4 of the randomized, blinded, placebo-controlled ...
Company closed $22M financing to support randomized Phase 2b trial; IND cleared and study initiated; Interim results anticipated in late 2026; topline data expected in H2/2027 ...
A team of scientists and physicians at Mass General Brigham has developed a single-dose oral cholera vaccine and tested it in ...
RAAINBOW-2 is an international, double-blind, placebo-controlled Phase 3 study for the treatment of moderate to severe alopecia areata (AA) in at least 500 subjects. -- Cinainu is the first topical ...
Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a monoclonal antibody that depletes CD19+ B cells, which are central to disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback